Capitalised terms used and not otherwise defined in this announcement have the meaning given to them in the Prospectus and/or the Circular. Important Information The person responsible for arranging for the release of this announcement on behalf of Target Healthcare REIT plc is Kenneth MacKenzie, Founder and Chief Executive of Target Fund Managers. The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment from time to time. This announcement which has been prepared by, and is the sole responsibility of, the Directors of the Company, has been approved solely for the purposes of section 21 of the Financial Services and Markets Act 2000, as amended, ( FSMA ) by the Investment Manager, which is authorised and regulated by the Financial Conduct Authority.
+44 (0) 207 379 5151
The person responsible for arranging and authorising the release of this announcement is Richard Cordeschi, Group Company Secretary of TP ICAP.
IMPORTANT NOTICE
This announcement has been issued by, and is the sole responsibility of, TP ICAP. No representation or warranty, express or implied, is or will be made by, or in relation to, and no responsibility or liability whatsoever is or will be accepted by Merrill Lynch International ( BofA Securities ) (as Joint Bookrunner and Lead Financial Adviser to TP ICAP), HSBC Bank plc ( HSBC ) (as Sole Sponsor in relation to the Rights Issue and the Re-domiciliation, Sole Global Co-ordinator, Joint Bookrunner and Financial Adviser to TP ICAP), J.P. Morgan Securities plc ( J.P. Morgan ) (as Joint Bookrunner to TP ICAP) and Peel Hunt LLP ( Peel Hunt ) (as Joint Bookrunner to TP ICAP), or any of their respective directors, officers, employees or advisers, or by any of their respective affiliates or agents, or any of thei
This announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company s plans and its current goals and expectations relating to its future financial condition and performance and which involve a number of risks and uncertainties. The Company cautions readers that no forward-looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as aim , anticipate , target , expect , estimate , intend , plan , goal , believe , or other words of similar meaning.
Further information This announcement is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Refinitiv transaction (the Transaction ) or otherwise, nor shall there be any sale, issuance or transfer of securities of LSEG in any jurisdiction in contravention of applicable law. Forward looking statements This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Transaction and other information published in connection with the Transaction contain statements which are, or may be deemed to be, forward-looking statements . Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations
Lucie Holloway, Sarah Bailey (Media) +44 (0)20 7797 1222 +44 (0)20 7797 3322 Paul Froud (Investors) Lucas van Praag, Philip Gawith, Doug Campbell +44 (0)20 7420 3183
This announcement is made on behalf of LSEG plc by Lisa Condron, the Group Company Secretary of LSEG plc. Further information This announcement is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Refinitiv transaction (the Transaction ) or otherwise, nor shall there be any sale, issuance or transfer of securities of LSEG in any jurisdiction in contravention of applicable law.